Regulation of insulin-like growth factor-dependent myoblast differentiation by foxo forkhead transcription factors

Journal of Cell Biology

Volumn 162, Issue 4, 2003, Pages 535-541

  Hribal, Marta L ^a   Nakae, Jun ^a   Kitamura, Tadahiro ^a   Shutter, John R ^b   Accili, Domenico ^a,c  

^a The New York Presbyterian Hospital   (United States)

^b AMGEN INC   (United States)

^c Berrie Research Pavilion   (United States)

Author keywords

Growth factors; Insulin signaling; Myogenesis; Phosphorylation; Serine kinases

Indexed keywords

INOSITOL PHOSPHATE; INSULIN; MYOSIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RAPAMYCIN; RNA; SMALL INTERFERING RNA; SOMATOMEDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FORKHEAD; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO FORKHEAD; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL AGGREGATION; CELL DIFFERENTIATION; CONTROLLED STUDY; FORKHEAD BOX GENE; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TERATOCARCINOMA;

ANDROSTADIENES; ANIMALS; CELL DIFFERENTIATION; ENZYME INHIBITORS; FORKHEAD TRANSCRIPTION FACTORS; MICE; MUTATION; MYOBLASTS; PROTEIN ISOFORMS; SIROLIMUS; SOMATOMEDINS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0042477748     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200212107     Document Type: Article

References (39)

1. Astolfi, A., C. De Giovanni, L. Landuzzi, G. Nicoletti, C. Ricci, S. Croci, L. Scopece, P. Nanni, and P.L. Lollini. 2001. Identification of new genes related to the myogenic differentiation arrest of human thabdomyosarcoma cells. Gene. 274:139-149.
2. Bois, P.R., and G.C. Grosveld 2003. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J. 22:1147-1157.
3. Brunet, A., A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:857-868.
4. Brunet, A., J. Park, H. Tran, L.S. Hu, B.A. Hemmings, and M.E. Greenberg. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell. Biol. 21:952-965.
5. Canicio, J., E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman. 1998. p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. Endocrinology 139:5042-5049.
6. Coleman, M.E., F. DeMayo, K.C. Yin, H.M. Lee, R. Geske, C. Montgomery, and R.J. Schwartz. 1995. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270:12109-12116.
7. Conejo R., C. de Alvaro, M. Benito, A. Cuadrado, and M. Lorenzo. 2002. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway. Oncogene. 21: 3739-3753.
8. Coolican, S.A., D.S. Samuel, D.Z. Ewton, F.J. McWade, and J.R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653-6662.
9. Cuenda, A., and P. Cohen. 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341-4346.
10. Erbay, E., and J. Chen. 2001. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 276:36079-36082.
11. Jiang, B.H., J.Z. Zheng, and P.K. Vogt. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc. Natl. Acad. Sci. USA. 95: 14179-14183.
12. Jiang, B.H., M. Aoki, J.Z. Zheng, J. Li, and P.K. Vogt. 1999. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA. 96:2077-2081.
13. Kaestner, K.H., W. Knochel, and D.E. Martinez. 2000. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14:142-146.
14. Kaliman P., J. Canicio, P.R. Shepherd, C.A. Beeton, X. Testar, M. Palacin, and A. Zorzano. 1998. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol. Endocrinol. 12:66-77.
15. Kim, J.J., and D. Accili. 2002. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm. IGF Res. 12:84-90.
16. Kitamura, T., J. Nakae, Y. Kitamura, Y. Kido, W.H. Biggs, III, C.V. Wright, M.F. White, K.C. Arden, and D. Accili. 2002. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest. 110:1839-1847.
17. Langley, B., M. Thomas, A. Bishop, M. Sharma, S. Gilmour, and R. Kambadur. 2002. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277:49831-49840.
18. Lawlor, M.A., and P. Rotwein. 2000a. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. J. Cell Biol. 151:1131-1140.
19. Lawlor, M.A., and P. Rotwein. 2000b. Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol. Cell. Biol. 20:8983-8995.
20. Lawlor, M.A., X. Feng, D.R. Everding, K. Sieger, C.E. Stewart, and P. Rotwein. 2000. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol. Cell. Biol. 20:3256-3265.
21. Leenders, H., S. Whiffield, C. Benoist, and D. Mathis. 2000. Role of the forkhead transcription family member, FKHR, in thymocyte differentiation. Eur. J. Immunol. 30:2980-2990.
22. Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
23. McKinsey, T.A., C.L. Zhang, and E.N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497-504.
24. Merlino, G., and L.J. Helman. 1999. Rhabdomyosarcoma-working out the pathways. Oncogene. 18:5340-5348.
25. Nakae, J., V. Barr, and D. Accili. 2000. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 19: 989-996.
26. Nakae, J., T. Kitamura, W. Ogawa, M. Kasuga, and D. Accili. 2001a. Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. Biochemistry. 40:11768-11776.
27. Nakae, J., T. Kitamura, D.L. Silver, and D. Accili. 2001b. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108:1359-1367.
28. Nakae, J., W.H. Biggs, T. Kitamura, W.K. Cavenee, C.V. Wright, K.C. Arden, and D. Accili. 2002. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32:245-253.
29. Nakae, J., T. Kitamura, Y. Kitamura, W.H. Biggs, K.C. Arden, and D. Accili. 2003. The forkhead transcription factor foxo1 regulates adipocyte differentiation. Dev. Cell. 4:119-129.
30. Olson, E.N., and W.H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
31. Rommel, C., S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, and D.J. Glass. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3:1009-1013.
32. Rosenthal, S.M., A. Brunetti, E.J. Brown, P.W. Mamula, and I.D. Goldfine. 1991. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J. Clin. Invest. 87:1212-1219.
33. Stewart, C.E., and P. Rotwein. 1996. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271:11330-11338.
34. Tapscott, S.J., M.J. Thayer, and H. Weintraub. 1993. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science. 259:1450-1453.
35. Tureckova, J., E.M. Wilson, J.L. Cappalonga, and P. Rotwein. 2001. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276:39264-39270.
36. Wang, W., P. Kumar, W. Wang, J. Epstein, L. Helman, J.V. Moore, and S. Kumar. 1998. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res. 58:4426-4433.
37. Weintraub, H., V.J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S.J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5:1377-1386.
38. Wilton, S., and I. Skerjanc. 1999. Factors in serum regulate muscle development in P19 cells. In Vitro Cell. Dev. Biol. Anim. 35:175-177.
39. Xu, Q., L. Yu, L. Liu, C.F. Cheung, X. Li, S.P. Yee, X.J. Yang, and Z. Wu. 2002. p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol. Biol. Cell. 13:1940-1952.